EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases

Toshihiko Motohara, Kensuke Yamamura, Hideaki Miyamoto, Shigenori Ueno, Hiroshi Takeno, Yasunori Nagayama, Eri Oda, Ryuichi Karashima, Nobuyuki Ozaki, Tatsunori Miyata, Kosuke Mima, Hirohisa Okabe und 2 weitere

In Vivo · 2023

DOI: 10.21873/invivo.13329 ↗

Kurz gefasst

Fallbericht in der Zeitschrift In Vivo, 2023. Verfasst von Toshihiko Motohara und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Yamaga City Medical Center, Kumamoto, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLung NeoplasmsFemaleHumansAgedBevacizumabAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

Atezolizumab plus bevacizumabdurable stable diseasehepatocellular carcinomalung metastasesmolecular therapy

Substanzen

BevacizumabatezolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Gastroenterology, Yamaga City Medical Center, Kumamoto, Japan.
  • Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
  • Department of Medical Oncology, Yamaga City Medical Center, Kumamoto, Japan.
  • Department of Diagnostic Radiology, Graduate School of Life Science, Kumamoto University, Kumamoto, Japan.
  • Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan; tbeppu@yamaga-mc.jp.

Zitieren

APA

Motohara, T., Yamamura, K., Miyamoto, H., Ueno, S., Takeno, H., Nagayama, Y., Oda, E., Karashima, R., Ozaki, N., Miyata, T., Mima, K., Okabe, H., Isiko, T., & Beppu, T. (2023). Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases. In Vivo. https://doi.org/10.21873/invivo.13329

Vancouver

Motohara T, Yamamura K, Miyamoto H, Ueno S, Takeno H, Nagayama Y, et al. Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases. In Vivo. 2023. doi:10.21873/invivo.13329

BibTeX
@article{Motohara2023,
  author = {Motohara, Toshihiko and Yamamura, Kensuke and Miyamoto, Hideaki and Ueno, Shigenori and Takeno, Hiroshi and Nagayama, Yasunori and Oda, Eri and Karashima, Ryuichi and Ozaki, Nobuyuki and Miyata, Tatsunori and Mima, Kosuke and Okabe, Hirohisa and Isiko, Takatoshi and Beppu, Toru},
  title = {Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases},
  journal = {In Vivo},
  year = {2023},
  doi = {10.21873/invivo.13329}
}
Kostenlos starten →